参考文献/References:
[1] Trichon BH, Felker GM, Shaw LK, et al. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure[J]. Am J Cardiol, 2003,91(5):538-543.
[2] Bursi F, Enriquez-Sarano M, Nkomo VT, et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation[J]. Circulation, 2005,111(3):295-301.
[3] Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases:a population-based study[J]. Lancet, 2006,368(9540):1005-1011.
[4] Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol, 2014,63(22):2438-2488.
[5] Ling LH, Enriquez-Sarano M, Seward JB, et al. Clinical outcome of mitral regurgitation due to flail leaflet[J]. N Engl J Med, 1996,335(19):1417-1423.
[6] Nemoto S, Hamawaki M, de Freitas G, et al. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation[J]. J Am Coll Cardiol, 2002,40(1):149-154.
[7] Ahmed MI, Aban I, Lloyd SG, et al. A randomized controlled phase Ⅱb trial of beta(1)-receptor blockade for chronic degenerative mitral regurgitation[J]. J Am Coll Cardiol, 2012,60(9):833-838.
[8] Tischler MD, Rowan M, LeWinter MM. Effect of enalapril therapy on left ventricular mass and volumes in asymptomatic chronic, severe mitral regurgitation secondary to mitral valve prolapse[J]. Am J Cardiol,1998,82(2):242-245.
[9] Harris KM, Aeppli DM, Carey CF. Effects of angiotensin-converting enzyme inhibition on mitral regurgitation severity, left ventricular size, and functional capacity[J]. Am Heart J, 2005,150(5):1106.
[10] Rowe JC, Bland EF, Sprague HB, et al. The course of mitral stenosis without surgery: ten- and twenty-year perspectives[J]. Ann Intern Med,1960,52:741-749.
[11] The SOLVD Investigattors.Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions[J]. N Engl J Med,1992,327(10):685-691.
[12] van Bommel RJ, Marsan NA, Delgado V, et al. Cardiac resynchronization therapy as a therapeutic option in patients with moderate-severe functional mitral regurgitation and high operative risk[J]. Circulation, 2011,124(8):912-919.
[13] Detaint D, Sundt TM, Nkomo VT, et al. Surgical correction of mitral regurgitation in the elderly: outcomes and recent improvements[J]. Circulation,2006,114(4):265-272.
[14] Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease(version 2012)[J]. Eur Heart J,2012,33(19):2451-2496.
[15] Enriquez-Sarano M, Schaff HV, Orszulak TA, et al. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis[J]. Circulation,1995,91(4):1022-1028.
[16] Gammie JS, O'Brien SM, Griffith BP, et al. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation[J]. Circulation,2007,115(7):881-887.
[17] Mehta RH, Eagle KA, Coombs LP, et al. Influence of age on outcomes in patients undergoing mitral valve replacement[J]. Ann Thorac Surg,2002,74(5):1459-1467.
[18] Alfieri O, Maisano F, de Bonis M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems[J]. J Thorac Cardiovasc Surg,2001,122(4):674-681.
[19] Maisano F, Caldarola A, Blasio A, et al. Midterm results of edge-to-edge mitral valve repair without annuloplasty[J]. J Thorac Cardiovasc Surg,2003,126(6):1987-1997.
[20] St GFG, Fann JI, Komtebedde J, et al. Endovascular edge-to-edge mitral valve repair: short-term results in a porcine model[J]. Circulation,2003,108(16):1990-1993.
[21] Silvestry FE, Rodriguez LL, Herrmann HC, et al. Echocardiographic guidance and assessment of percutaneous repair for mitral regurgitation with the Evalve MitraClip: lessons learned from EVERESTⅠ[J]. J Am Soc Echocardiogr,2007,20(10):1131-1140.
[22] Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation[J]. N Engl J Med, 2011,364(15):1395-1406.
[23] Glower D, Ailawadi G, Argenziano M, et al. EVEREST Ⅱ randomized clinical trial: predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure[J]. J Thorac Cardiovasc Surg,2012,143(4 Suppl):s60-s63.
[24] Mauri L, Foster E, Glower DD, et al. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation[J]. J Am Coll Cardiol, 2013,62(4):317-328.
[25] Seeburger J, Rinaldi M, Nielsen SL, et al. Off-pump transapical implantation of artificial neo-chordae to correct mitral regurgitation: the TACT Trial(Transapical Artificial Chordae Tendinae)proof of concept[J]. J Am Coll Cardiol,2014,63(9):914-919.
[26] Herrmann HC, Maisano F. Transcatheter therapy of mitral regurgitation[J]. Circulation, 2014,130(19):1712-1722.
[27] Harnek J, Webb JG, Kuck KH, et al. Transcatheter implantation of the MONARC coronary sinus device for mitral regurgitation:1-year results from the EVOLUTION phase I study(Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for the Treatment of Mitral Regurgitation)[J]. JACC Cardiovasc Interv,2011,4(1):115-122.
[28] Maselli D, Guarracino F, Chiaramonti F, et al. Percutaneous mitral annuloplasty:an anatomic study of human coronary sinus and its relation with mitral valve annulus and coronary arteries[J]. Circulation,2006,114(5):377-380.
[29] Schofer J, Siminiak T, Haude M, et al. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study[J]. Circulation,2009,120(4):326-333.
[30] Kim JH, Kocaturk O, Ozturk C, et al. Mitral cerclage annuloplasty, a novel transcatheter treatment for secondary mitral valve regurgitation: initial results in swine[J]. J Am Coll Cardiol,2009,54(7):638-651.
[31] Maisano F, Vanermen H, Seeburger J, et al. Direct access transcatheter mitral annuloplasty with a sutureless and adjustable device: preclinical experience[J]. Eur J Cardiothorac Surg, 2012,42(3):524-529.
[32] Mandinov L, Bullesfeld L, Kuck KH, et al. Early insight into Mitralign direct annuloplasty for treatment of functional mitral regurgitation[J]. Interv Cardiol Rev,2011,6:170-172.
[33] Banai S, Verheye S, Cheung A, et al. Transapical mitral implantation of the Tiara bioprosthesis: pre-clinical results[J]. JACC Cardiovasc Interv,2014,7(2):154-162.